Novel Insights into Antiplatelet Therapy in Cardiovascular Disease
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiovascular Medicine".
Deadline for manuscript submissions: closed (25 April 2025) | Viewed by 304
Special Issue Editor
Interests: chronic total occlusion; percutaneous coronary intervention; coronary artery disease; drug-eluting stent; left coronary artery
Special Issue Information
Dear Colleagues,
Cardiovascular disease management has evolved significantly with advancements in antiplatelet therapy. This Special Issue delves into cutting-edge insights across several key areas of antiplatelet treatment in cardiovascular disease. It explores various modification strategies, such as de-escalation and escalation, with or without specific guidances, and the integration of novel oral anticoagulants with antiplatelet agents in coronary artery disease. Additionally, it includes rapidly evolving antiplatelet therapy strategies for structural heart disease interventions, such as transcatheter aortic valve replacement. Personalized antiplatelet therapy, which tailors treatment to individual patient needs and risk profiles, is also a critical focus. Research on diagnostic tools and strategies to support personalized approaches is particularly encouraged. Contributions to this Special Issue aim to provide comprehensive updates and discussions on optimizing therapeutic strategies, in managing various risk populations, thereby improving overall clinical outcomes.
Dr. Osung Kwon
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antiplatelet therapy
- cardiovascular disease
- platelet aggregation
- thrombosis prevention
- platelet function
- anticoagulation
- personalized medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
